SUN PHARMACEUTICAL IND L vs SUVEN LIFE SCIENCES LTD

A side-by-side comparison of SUN PHARMACEUTICAL IND L (SUNPHARMA) and SUVEN LIFE SCIENCES LTD (SUVEN) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, SUN PHARMACEUTICAL IND L leads SUNPHARMA vs SUVEN on 10 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability40
  • Growth10
  • Size & financial health31

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

40.28
P/E ratio
-29.50
20.07
P/B ratio
13.30
0.84%
Dividend yield
0.00%
₹47.84
EPS
₹-10.48

Profitability

SUNPHARMA takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

16.00%
Return on equity
-78.80%
21.00%
Return on capital
-77.00%
30.00%
EBITDA margin
-4001.00%
19.69%
Net margin
-3942.86%

Growth

SUNPHARMA takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.03%
Revenue CAGR (3Y)
-20.63%
10.57%
Profit CAGR (3Y) even

Size & financial health

SUNPHARMA takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹4.63L Cr
Market cap
₹10,090 Cr
₹58,462 Cr
Revenue
₹7 Cr
₹11,509 Cr
Net profit
₹-276 Cr
0.61
Debt / equity
0.01
SUN PHARMACEUTICAL IND L
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
  • ["The company has delivered a poor sales growth of 11.8% over past five years."]
SUVEN LIFE SCIENCES LTD
  • + ["Company is almost debt free."]
  • ["Stock is trading at 16.3 times its book value", "Company has low interest coverage ratio.", "Promoter holding has decreased over last quarter: -4.68%", "The company has delivered a poor sales growth of -12.0% over past five years.", "Company has a low return on equity of -65.9% over last 3 years.", "Debtor days have increased from 63.7 to 77.5 days.", "Working capital days have increased from 55.6 days to 506 days"]
SUN PHARMACEUTICAL IND L full analysis SUVEN LIFE SCIENCES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

SUNPHARMA vs SUVEN: Share Price, Valuation & Which to Buy | DocStoX